Radiopharm Theranostics Limited American Depositary Shares (RADX)

• Market cap: $32.4M
• 1 day: -5.23%
• 5 days: -0.24%
• 1 month: -2.34%
• 3 months: -7.33%
• 6 months: -76.40%
• Year to date: -10.13%
• 1 year: -76.40%
• 5 years: -76.40%
• 10 years: -76.40%
• Sector: Healthcare
• Industry: Biotechnology

About: Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

0.02% more ownership

Funds ownership: 0% [Q3] → 0.02% (+0.02%) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $12 188% upside
• Avg. target: $13.50 224% upside
• High target: $15 260% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Maxim Group Michael Okunewitch 0% 1-year accuracy 0 / 9 met price target	188% upside $12	Buy Initiated	1 May 2025
B. Riley Securities Yuan Zhi 44% 1-year accuracy 4 / 9 met price target	260% upside $15	Buy Initiated	12 Mar 2025